School of Engineering faculty and students are working to overcome the challenges—technological, environmental, and political—associated with the “New Deal” infrastructure project of the century.
Morphoceuticals Inc, a company co-founded by Stern Family Professor David Kaplan, recently raised $8 million to advance electroceutical approaches to regenerative medicine.